Literature DB >> 17284151

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania.

Vladimir Coric, Ben Kelmendi, Christopher Pittenger, Susanne Wasylink, Michael H Bloch, Jeff Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17284151     DOI： 10.4088/jcp.v68n0123f

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  10 in total

Review 1.  Diagnosis, evaluation, and management of trichotillomania.

Authors:  Douglas W Woods; David C Houghton
Journal:  Psychiatr Clin North Am       Date:  2014-07-21

Review 2.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

Review 3.  Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder.

Authors:  Paul Grant; Jane Y Song; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

Review 4.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  Riluzole in psychiatry: a systematic review of the literature.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-09       Impact factor: 4.481

Review 6.  Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings.

Authors:  Marc N Potenza
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

7.  Pathological Gambling: Biological and Clinical Considerations.

Authors:  Jocelyn L Topf; Sarah W Yip; Marc N Potenza
Journal:  J Addict Med       Date:  2009-09-01       Impact factor: 3.702

Review 8.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

9.  Inducible nitric oxide synthase (NOS2) knockout mice as a model of trichotillomania.

Authors:  Plinio C Casarotto; Caroline Biojone; Karina Montezuma; Fernando Q Cunha; Samia R L Joca; Eero Castren; Francisco S Guimaraes
Journal:  PeerJ       Date:  2018-04-17       Impact factor: 2.984

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.